Description
Description
Piperacillin and Tazobactam is a compound anti-infective drug composed of piperacillin (semi-synthetic penicillin antibiotic) and tazobactam (β-lactamase inhibitor). It is suitable for moderate and severe infections which are resistant to piperacillin, caused by beta-lactamase-producing bacteria that are sensitive to piperacillin and tazobactam. Piperacillin and Tazobactam were jointly developed by Pfizer, Wyeth, and Taisho Corporation of Japan. Piperacillin and tazobactam were approved in China in 1996 and were included in the national medical insurance in China in 2009. As of the end of 2020, there are more than 20 manufacturers in the piperacillin sodium and tazobactam sodium market in China, of which Pfizer Ltd has the largest market share.
According to CRI’s market research, the sales of Piperacillin and Tazobactam in the Chinese market increased year by year from 2016 to 2019. Due to the impact of the new crown epidemic on the overall medical diagnosis and treatment services, the sales decreased from CNY1.681 billion in 2019 to CNY1.436 billion in 2020, with a year-on-year decrease of 14.6%. The CAGR of sales of piperacillin sodium and tazobactam sodium from 2016 to 2020 is 3.28%.
CRI predicts that the sales of Piperacillin and Tazobactam will have a restorative growth from 2021 to 2025 with the effective alleviation of the Covid-19 epidemic. In addition, Piperacillin/Tazobactam has good clinical effects and few adverse reactions. Piperacillin/Tazobactam is more effective and safer for the treatment of lower respiratory tract infections and urinary tract infections caused by beta-lactamase-producing strains compared with similar drugs. Based on these advantages, the sales of piperacillin and tazobactam will increase steadily in the future.
Topics Covered:
-The impact of COVID-19 on China’s Piperacillin and Tazobactam market
– Sales value of China’s Piperacillin and Tazobactam 2016-2020
– Competitive landscape of China’s Piperacillin and Tazobactam market
– Prices of Piperacillin and Tazobactam in China
– Prices of Piperacillin and Tazobactam in China by regions and manufacturers
– Analysis of factors affecting the development of China’s Piperacillin and Tazobactam market
– Prospect of China’s Piperacillin and Tazobactam market from 2021 to 2025